Which closed-end funds own Teva Pharmaceutical Finance Netherlands III Bv?
12 active closed-end funds report this security in their latest N-PORT filing, with a combined reported value of $11.7M. Security type: debt security. Country: Netherlands. CUSIP 88167AAF8 · ISIN US88167AAF84 · ticker TEVA.
Holdings are historical filings (report dates May 29, 2026 – Jul 31, 2026; N-PORT becomes public ~60 days after quarter end), not live positions. Weights are percent of each fund’s net assets. Different instruments of one issuer (shares, bonds, preferreds) are separate securities — see related securities below.
Funds holding this security
| Fund | Category | Weight | Value (USD) | Balance | Fund net assets | Prem/disc | Report date |
|---|---|---|---|---|---|---|---|
| HIO Western Asset High Income Opportunity Fund | High Yield | 0.54% | $2M | 2,550,000 par | $367M | 11.3% discount | Jun 30, 2026 |
| VLT Invesco High Income Trust II | High Yield | 0.51% | $517K | 678,000 par | $101M | 11.5% discount | May 31, 2026 |
| HYI Western Asset High Yield Opportunity Fund | High Yield | 0.47% | $702K | 920,000 par | $149M | 11.4% discount | May 29, 2026 |
| EMD Western Asset Emerging Markets Debt Fund | Taxable Bonds | 0.36% | $3.1M | 4,000,000 par | $852M | 11.3% discount | Jun 30, 2026 |
| WDI Western Asset Diversified Income Fund (WDI) | Multi-Asset | 0.31% | $2.3M | 3,000,000 par | $737M | 12.2% discount | Jun 30, 2026 |
| EVV Eaton Vance Ltd Duration Income Fund | Taxable Bonds | 0.12% | $2.1M | 2,726,000 par | $1.7B | 12.7% discount | Jun 30, 2026 |
| EVG Eaton Vance Short Duration Diversified Income Fund | Multi-Asset | 0.08% | $150K | 203,000 par | $176M | 5.7% discount | Jul 31, 2026 |
| JHS John Hancock Income Securities Trust | Taxable Bonds | 0.08% | $192K | 261,000 par | $229M | 10.8% discount | Jul 31, 2026 |
| WEA Western Asset Premier Bond Fund | Taxable Bonds | 0.08% | $154K | 200,000 par | $191M | 9.3% discount | Jun 30, 2026 |
| HIX Western Asset High Income Fund II | High Yield | 0.07% | $354K | 480,000 par | $513M | NAV unavailable | Jul 31, 2026 |
| GDO Western Asset Global Corporate Opportunity Fund | Multi-Asset | 0.06% | $73.8K | 100,000 par | $121M | 6.9% discount | Jul 31, 2026 |
| VBF Invesco Bond Fund | Taxable Bonds | 0.04% | $67.2K | 88,000 par | $187M | 7.3% discount | May 31, 2026 |
12 positions. Source: SEC Form N-PORT via market-data vendor re-serve. Funds without an N-PORT on file cannot appear here.
Also listed in filings as: TEVA PHARMACEUTICALS NE; Teva Pharmaceutical Finance Netherlands III B.V..
Related securities from the same issuer
| Security | Type | Funds holding |
|---|---|---|
| Teva Pharmaceutical Finance Netherlands III Bv | debt security | 11 |
| Teva Pharmaceutical Finance Netherlands III Bv | debt security | 10 |
| Teva Pharmaceutical Finance Netherlands III Bv | debt security | 7 |
| Teva Pharmaceutical Industries Ltd | common equity | 6 |
| Teva Pharmaceutical Finance Netherlands III Bv | debt security | 5 |
| Teva Pharmaceutical Indu | debt security | 3 |
| Teva Pharmaceutical Finance Company LLC | debt security | 2 |
| Teva Pharmaceutical Finance Netherlands IV B.V. | debt security | 2 |
| Teva Pharmaceuticals Ne | debt security | 1 |
| Teva Pharmaceutical Finance Netherlands II B.V. | debt security | 1 |
| Teva Pharmaceutical Finance Netherlands II B.V. | debt security | 1 |
| Teva Pharmaceuticals Ne | debt security | 1 |
Issuer-level search for “TEVA” → · Compare two funds’ portfolios →